ArticleFrontiers in immunology2023

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies.

Zixue Xuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.